RNA sequencing data suggests that NAT1 may regulate liver metastasis of colorectal cancer through the PI3K/AKT/mTOR signaling pathway and inhibits the expression of glycolytic-related metabolic enzymes such as GLUT1 and LDHA. Here, SLC2A1 is linked to colorectal cancer.